Dendrimers for cancer immunotherapy: Avidity‐based drug delivery vehicles for effective anti‐tumor immune response

Corresponding Author

Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin-Madison, Madison, Wisconsin, USA

Wisconsin Center for NanoBioSystems, University of Wisconsin-Madison, Madison, Wisconsin, USA

Department of Pharmacy, Yonsei University, Incheon, Republic of Korea

Yonsei Frontier Lab, Yonsei University, Seoul, Republic of Korea

Correspondence

Seungpyo Hong, Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin-Madison, Madison, WI 53705, USA.

Contribution: Conceptualization (lead), Funding acquisition (lead), Resources (lead), Supervision (lead), Writing - review & editing (lead)

View original article

0 0 0 0 0 0 0

Comments (0)